MRK registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Dec 31, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Primary completion date | Nov 19, 2030 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Primary completion date | Oct 30, 2025 (actual) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Primary completion date | Dec 27, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Primary completion date | Dec 2033 (sponsor estimate) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Primary completion date | Jul 2, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Primary completion date | Jan 29, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Primary completion date | Oct 28, 2026 (actual) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Primary completion date | Mar 29, 2027 (sponsor estimate) | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion date
- Now
- Dec 31, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETPrimary completion date
- Now
- Nov 19, 2030 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETPrimary completion dateNCT04652076GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or PembrolizumabMRK
- Now
- Oct 30, 2025 (actual)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETPrimary completion dateNCT06502743First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without...MRK
- Now
- Dec 27, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETPrimary completion dateNCT07015853ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and RadiationMRKINCY
- Now
- Dec 2033 (sponsor estimate)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETPrimary completion dateNCT07159763A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)MRK
- Now
- Jul 2, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETPrimary completion dateNCT06688058A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)MRK
- Now
- Jan 29, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETPrimary completion date
- Now
- Oct 28, 2026 (actual)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETPrimary completion dateNCT07133633A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)MRK
- Now
- Mar 29, 2027 (sponsor estimate)
- Before
- Locked
The previous value and the sponsor's record update date are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.